FOSCAN

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom

Active ingredients

The drug FOSCAN contains one active pharmaceutical ingredient (API):

1 Temoporfin UNII FU21S769PF - TEMOPORFIN

Temoporfin is a photosensitising agent used in the photodynamic therapy of tumours. Read about Temoporfin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FOSCAN Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XD05	Temoporfin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XD Sensitizers used in photodynamic/radiation therapy
Discover more medicines within L01XD05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1208438, 1208449, 1364251, 1364262, 1364273
Country: FR	Base de données publique des médicaments	Identifier(s): 61430956, 67009330
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 215583, 215586
Country: IT	Agenzia del Farmaco	Identifier(s): 036433011, 036433023, 036433035, 036433047, 036433050
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1028598, 1028599, 1028600, 1028601, 1028602
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 138290, 138304
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100244390